Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
Víctor G. Martínez, Ester Munera-Maravilla, Alejandra Bernardini, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
Martina Minoli, Mirjam Kiener, George N. Thalmann, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5670-5670
Open Access | Times Cited: 72
Patient‐derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR‐T cells in vitro
Lei Yu, Zhichao Li, Hongbin Mei, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 2
Open Access | Times Cited: 64
Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression
Zhixin Huang, Mengzhao Zhang, Guanqiu Chen, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 39
Computational methods and next-generation sequencing approaches to analyze epigenetics data: Profiling of methods and applications
Itika Arora, Trygve O. Tollefsbol
Methods (2020) Vol. 187, pp. 92-103
Open Access | Times Cited: 39
A Comprehensive Review of Current Approaches in Bladder Cancer Treatment
Soniya Kumbham, Kazi Md Mahabubur Rahman, Barbara A. Foster, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 2, pp. 286-307
Closed Access
Recent animal models of bladder cancer and their application in drug discovery: an update of the literature
Inês Aires, B. Parada, Rita Ferreira, et al.
Expert Opinion on Drug Discovery (2025)
Closed Access
Functional Nanomedicines for Targeted Therapy of Bladder Cancer
Chao Tang, Heng Liu, Yanpeng Fan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26
An Introduction to Fundamentals of Cancer Biology
S. Sriharikrishnaa, Padmanaban S. Suresh, Shama Prasada Kabekkodu
Biological and medical physics series (2023), pp. 307-330
Closed Access | Times Cited: 9
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer
Sandra P. Nunes, Lucía Morales, Carolina Rubio, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
(-)-Epigallocatechin-3-Gallate Prevents IL-1β-Induced uPAR Expression and Invasiveness via the Suppression of NF-κB and AP-1 in Human Bladder Cancer Cells
Dhiraj Kumar Sah, Pham Ngoc Khoi, Shinan Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14008-14008
Open Access | Times Cited: 14
Overexpression of KMT9α Is Associated with Aggressive Basal-like Muscle-Invasive Bladder Cancer
Florestan Koll, Eric Metzger, Jana Hamann, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 589-589
Open Access | Times Cited: 8
The metabolic landscape of urological cancers: New therapeutic perspectives
Vera Miranda‐Gonçalves, Ana Lameirinhas, Rui Henrique, et al.
Cancer Letters (2020) Vol. 477, pp. 76-87
Closed Access | Times Cited: 22
Down‐regulation and clinical significance of Sorbin and SH3 domain‐containing protein 1 in bladder cancer tissues
Sheng‐Hua Li, Gao‐Qiang Zhai, Rong‐Quan He, et al.
IET Systems Biology (2023) Vol. 17, Iss. 2, pp. 70-82
Open Access | Times Cited: 7
Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells’ Pluripotency in Bladder Cancer
Carolina Rubio, José Avendaño‐Ortiz, Raquel Ruiz-Palomares, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 287-287
Open Access | Times Cited: 11
Diagnostic and prognostic potential clustered miRNAs in bladder cancer
Akshay Pramod Ware, Shama Prasada Kabekkodu, Arun Chawla, et al.
3 Biotech (2022) Vol. 12, Iss. 8
Open Access | Times Cited: 11
Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
Alba Loras, Cristina Segovia, José Luis Ruiz-Cerdá
Cancers (2021) Vol. 13, Iss. 11, pp. 2719-2719
Open Access | Times Cited: 13
Emerging molecular mechanisms and genetic targets for developing novel therapeutic strategies for treating bladder diseases
Randa Zoqlam, Sandra Lazauskaite, Scott Glickman, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 173, pp. 106167-106167
Open Access | Times Cited: 9
H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets
Liliana Burlibașa, Alina-Teodora Nicu, Mariana Carmen Chifiriuc, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Fourier transform IR imaging of primary tumors predicts lymph node metastasis of bladder carcinoma
Monika Kujdowicz, David Pérez-Guaita, Piotr Chłosta, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 8, pp. 166840-166840
Open Access | Times Cited: 5
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer
L Picard, Fenella J. Rich, Diane Kenwright, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189123-189123
Open Access | Times Cited: 1
Bladder cancer biomarkers: current approaches and future directions
Melika Ahangar, Frouzandeh Mahjoubi, Seyed Javad Mowla
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Epigenetic inactivation of DNA repair genes as promising prognostic and predictive biomarkers in urothelial bladder carcinoma patients
Marwa Mohanad, Hend F. Yousef, Abeer A. Bahnassy
Molecular Genetics and Genomics (2022) Vol. 297, Iss. 6, pp. 1671-1687
Open Access | Times Cited: 6
N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer
Jiancheng Lv, Qiang Song, Kexin Bai, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Alterations of histone modifications in cancer
Maha Saber-Ayad, Wafaa S. Ramadan, Raafat El‐Awady
Elsevier eBooks (2023), pp. 85-172
Closed Access | Times Cited: 3
Screening of hub genes and prediction of putative drugs in arsenic-related bladder carcinoma: An in silico study
Liang Zhang, Yan Zhou, Jingfang Zhang, et al.
Journal of Trace Elements in Medicine and Biology (2020) Vol. 62, pp. 126609-126609
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top